Insurers prohibited from discriminating against people with prescription naloxone

Under a new law, when an insurer is determining whether to issue, renew, cancel or modify a life insurance policy, they cannot make an underwriting determination based solely on information revealing that a proposed insured has a prescription for an opiate antagonist.

An “opiate antagonist” means naloxone hydrochloride or any similarly acting drug approved by the federal Food and Drug Administration for the treatment of a drug overdose.

Effective Aug. 1, 2021, the law is sponsored by Rep. Erin Koegel (DFL-Spring Lake Park) and Sen. Mark Koran (R-North Branch).

HF652*/SF837/CH10

HF0652* / SF0837 / CH10